Vijayalakshmi T, Muthulakshmi V, Sachdanandam P
Department of Medical Biochemistry, University of Madras, India.
J Ethnopharmacol. 1997 Sep;58(1):1-8. doi: 10.1016/s0378-8741(97)00074-3.
Lysosomal acid hydrolases are thought to play an important role in inflammation associated with rheumatoid arthritis. A Siddha preparation of Semecarpus anacardium nut extract called Serankottai Nei was tested for its capacity to stabilize lysosomes obtained from liver and kidney of adjuvant-induced arthritic animals. Lysosomal membrane stability was measured by determining the release of acid hydrolases from the lysosomes. The drug was administered at a dose level of 150 mg/kg body weight for 14 days to arthritic animals after the adjuvant injection. The total and free activity of lysosomal enzymes were significantly increased in arthritic rats with concomitant increase in plasma levels of protein-bound carbohydrates. Significantly increased lysosomal membrane fragility as observed in arthritic condition was reduced in drug-treated animals. Antiarthritic activity of the drug through its stabilizing action on lysosomal membranes could be inferred from this study.
溶酶体酸性水解酶被认为在类风湿性关节炎相关的炎症中起重要作用。一种名为Serankottai Nei的印度悉达医学制剂,即印度马钱子坚果提取物,被测试其稳定从佐剂诱导性关节炎动物的肝脏和肾脏中获得的溶酶体的能力。通过测定酸性水解酶从溶酶体中的释放来测量溶酶体膜稳定性。在佐剂注射后,以150mg/kg体重的剂量水平给关节炎动物给药该药物14天。关节炎大鼠中溶酶体酶的总活性和游离活性显著增加,同时血浆中蛋白结合碳水化合物水平也增加。在药物治疗的动物中,关节炎状态下观察到的显著增加的溶酶体膜脆性降低。从这项研究中可以推断出该药物通过其对溶酶体膜的稳定作用而具有抗关节炎活性。